ICMJE recommendations update: what you need to know
Find out what’s new in the latest 2022 update to the ICMJE recommendations.
[VIDEO] Introducing GPP 2022
Find out what’s covered in the 2022 update to the Good Publication Practice guidelines.
CHEERS 2022 statement: reporting guidance for health economic evaluations gets a makeover
Read about the new 28-item checklist developed to aid decision-making in health economic evaluations.
What can be done to increase the transparency of real world studies?
Read about recent roundtable recommendations for improving the transparency of real world evidence dissemination.
What counts as a ‘substantial contribution’ to industry-sponsored research?
Recommendations from the ISMPP Authorship Task Force aim to clarify ICMJE guidelines on authorship selection criteria.
Is open research driving inequity in science?
Dr Tony Ross-Hellauer (ON-MERRITT) discusses how the move toward open research may exacerbate inequity and suggests strategies to prevent it.
How to assess the credibility of clinical trial findings?
Read about Cochrane reviewers’ approaches to detecting and tackling potential fraud in clinical trial publications.
Meeting report: summary of Day 2 of the 2022 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!
Meeting report: summary of Day 1 of the 2022 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!
Artificial intelligence in health: how to ensure it’s ethical and beneficial to everyone?
World Health Organization provides 6 principles for regulation and governance of the technology.
Codes of conduct for research integrity: are they fit for purpose?
European countries can’t agree on what counts as research misconduct, creating potential pitfalls for researchers.
Meeting report: summary of session 1 of the 9th EMWA symposium
Missed the meeting? Read our report to get up to speed!
The latest updates to ICMJE’s reporting recommendations
The ICMJE recently updated its recommendations, providing guidance on issues such as use of preprint servers, conflict of interest reporting and journal metrics.
How to overcome the issue of poorly reported clinical trial outcomes
A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.
New recommendations to improve authorship transparency
How can journals, institutions, funders and societies improve and standardise the current authorship system?